Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Science Translational Medicine, 2025
Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8 + T cells with a disease-associated TCR signature

Lundgren S., Huuhtanen J., Keränen M. et al.

Olink Target 96HematologyPathophysiologyPlasma

Experimental Dermatology, 2025
Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity

Ran Y., Peng X., Xia Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum

Arthritis & Rheumatology, 2025
Plasma Proteomic Profiles Predict Individual Future Osteoarthritis Risk

Kang Z., Zhang J., Liu W. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationPlasma

Journal for ImmunoTherapy of Cancer, 2025
Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer

Roudko V., Del Valle D., Radkevich E. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationSerum

PLOS ONE, 2025
Exploratory study of serum protein biomarkers for sudden cardiac arrest using protein extension assay: A case-control study

Shin H., Park J., Cha K. et al.

Olink Target 96CVDPatient StratificationSerum

OncoImmunology, 2025
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade

Rocha P., Bach R., Masfarré L. et al.

Olink Explore 3072/384OncologyImmunotherapyPatient StratificationSerum

Virus Genes, 2025
Plasma proteins and herpes simplex virus infection: a proteome-wide Mendelian randomization study

Fu C., Xu W., Xu X. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

Nature Genetics, 2025
Whole-genome sequencing analysis identifies rare, large-effect noncoding variants and regulatory regions associated with circulating protein levels

Hawkes G., Chundru K., Jackson L. et al.

Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

Nature Communications, 2025
Comparative studies of 2168 plasma proteins measured by two affinity-based platforms in 4000 Chinese adults

Wang B., Pozarickij A., Mazidi M. et al.

Olink Explore 3072/384Wider Proteomics StudiesCross-platform ValidationPlasma

Cell Genomics, 2025
Contribution of germline and somatic mutations to risk of neuromyelitis optica spectrum disorder

Yata T., Sato G., Ogawa K. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Annals of Neurology, 2025
Distinct Alterations of Inflammatory Biomarkers in Cluster Headache: A Case Control Study

Lund N., Westgate C., Søborg M. et al.

Olink Target 48NeurologyPathophysiologyPatient StratificationPlasma

Journal of Inflammation Research, 2025
Identification of Cardiometabolic Protein Biomarkers for Acute Myocardial Infarction Using Olink Proteomics

Tan X., Wang X., Xu S. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Nature Aging, 2025
Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers

Gan Y., Ma L., Zhang Y. et al.

Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationPlasma

Cardiovascular Diabetology, 2025
Phenotype-based clusters, inflammation and cardiometabolic complications in older people before the diagnosis of type 2 diabetes: KORA F4/FF4 cohort study

Huemer M., Spagnuolo M., Maalmi H. et al.

Olink Target 96Metabolic DiseasesPatient StratificationSerum

Nature Medicine, 2025
Integrating the environmental and genetic architectures of aging and mortality

Argentieri M., Amin N., Nevado-Holgado A. et al.

Olink Explore 3072/384Wider Proteomics StudiesAgingPathophysiologyPlasma

Brain, Behavior, and Immunity, 2025
Developmental stage of childhood trauma exposure and markers of inflammation at age 24

Murphy J., Healy C., Mongan D. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Clinical Cancer Research, 2025
Clinical and Translational Results from PORTER, a Multi-cohort Phase 1 Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

Galsky M., Autio K., Cabanski C. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerum

Clinical Proteomics, 2025
Admission glucose, HbA1c levels and inflammatory cytokines in patients with acute ST-elevation myocardial infarction

Christa M., Dennis F., Philip R. et al.

Olink Target 96CVDPatient StratificationPlasma

ESMO Open, 2025
First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors

Naing A., McKean M., Rosen L. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Gastric Cancer, 2025
Investigating the role of inflammatory cytokines in mediating the effect of gut microbiota on gastrointestinal cancers: a mendelian randomization study

Liu W., Hu X., Choy Y. et al.

Olink Target 96OncologyPathophysiologyPlasma

2965 publications